GNH India, a leading global pharmaceutical distributor, has received clearance from the Kenyan Pharmacy and Poisons Board through an independent audit which will allow the company to export scheduled drugs to Kenya.
The company will export the first shipment of lifesaving drugs to Kenya shortly and is looking to establish long lasting business relations with the country. The country, which has been facing a dearth of many lifesaving drugs in recent times will be benefited by this development.
The Pharmacy and Poisons Board is the drug regulatory authority established under the Pharmacy and Poisons Act, Chapter 244 of the laws of Kenya, and is responsible for regulating the practice of pharmacy and the manufacture and trade in drugs and poisons in Kenya.
Commenting on this, Dr Piyush Gupta, associate director, GNH India said, “GNH India has always believed that everyone should have access to proper healthcare and medicines, and we strive to deliver the same to the people irrespective of the global boundaries. We always adhere to appropriate practices and maintain quality standards while servicing our clients, and being certified by The Pharmacy and Poisons Board, Kenya authenticates the measures taken by us for the exports of medicines. It gives us tremendous pleasure to be the first Indian specialized wholesaler to clear the audit by any foreign body, and we look forward to many more opportunities.”
GNH India, exports to more than 180 countries and has 1,35,000 product lines to choose from which makes this company one of the leading businesses in the $12.5 billion Indian pharmaceutical export industry. This recent development has extended their reach into Kenya which has added to the long list of countries they already export medicines to. GNH India had recently also exported a large consignment of LSD to Yemen amongst other countries in Africa and the Middle East.
GNH India was audited in compliance to Good Distribution Practices (GDP), the criteria of the audit are based on World Health Organization’s (WHO) Good Distribution Practices for pharmaceutical products and European Union’s guidelines on GDP of medical products for human use. Kenya is currently facing the shortage of the lifesaving drugs, which are used in ICU. The certification by the Board will allow GNH India to ship lifesaving drugs for ICU to Kenya.
With over 30 years of expertise, GNH India is a global source for priority medicines. The company is committed to excellence by providing high-quality products, at competitive prices, with fast and reliable service, while remaining true to the core values of accountability, ethical business practices, and innovation.
GNH India is an independent and professionally run full-line pharma wholesaler who ships over 1,35,000 product lines to more than 180 countries worldwide. The company acts as an adapter between Indian operating environment and international quality expectations, helping hospitals, ministries, importers, wholesalers, pharmacists, doctors, etc. with an unmatched confidence.